Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2018, Article ID 3407306, 12 pages
https://doi.org/10.1155/2018/3407306
Review Article

The Impact of Obesity on the Cardiovascular System

1Department of Emergency Medicine, Faculty of Medicine, University of Debrecen, Hungary
2Division of Metabolism, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Hungary
3Division of Clinical Pharmacology, Faculty of Pharmacy, University of Debrecen, Hungary

Correspondence should be addressed to Zoltán Szabó; moc.liamg@dem.zobazs

Imre Csige and Dóra Ujvárosy contributed equally to this work.

Received 12 July 2018; Revised 12 September 2018; Accepted 27 September 2018; Published 4 November 2018

Guest Editor: Gaetano Santulli

Copyright © 2018 Imre Csige et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Ng, T. Fleming, M. Robinson et al., “Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013,” The Lancet, vol. 384, no. 9945, pp. 766–781, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Poirier, T. D. Giles, G. A. Bray et al., “Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism,” Circulation, vol. 113, no. 6, pp. 898–918, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Zeller, P. G. Steg, J. Ravisy et al., “Relation between body mass index, waist circumference, and death after acute myocardial infarction,” Circulation, vol. 118, no. 5, pp. 482–490, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Yusuf, S. Hawken, S. Ôunpuu et al., “Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study,” The Lancet, vol. 364, no. 9438, pp. 937–952, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Ashwell and S. D. Hsieh, “Six reasons why the waist-to-height ratio is a rapid and effective global indicator for health risks of obesity and how its use could simplify the international public health message on obesity,” International Journal of Food Sciences and Nutrition, vol. 56, no. 5, pp. 303–307, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. V. Z. Rocha and P. Libby, “Obesity, inflammation, and atherosclerosis,” Nature Reviews Cardiology, vol. 6, no. 6, pp. 399–409, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Ross, “Atherosclerosis--an inflammatory disease,” The New England Journal of Medicine, vol. 340, no. 2, pp. 115–126, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. S. E. Shoelson, L. Herrero, and A. Naaz, “Obesity, inflammation, and insulin resistance,” Gastroenterology, vol. 132, no. 6, pp. 2169–2180, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. P. M. Ridker, “C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus,” Journal of the American College of Cardiology, vol. 49, no. 21, pp. 2129–2138, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. A. D. Pradhan, J. E. Manson, N. Rifai, J. E. Buring, and P. M. Ridker, “C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus,” Journal of the American Medical Association, vol. 286, no. 3, pp. 327–334, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Esposito, A. Pontillo, C. di Palo et al., “Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial,” JAMA, vol. 289, no. 14, pp. 1799–1804, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. H. C. McGill, C. A. McMahan, E. E. Herderick et al., “Obesity accelerates the progression of coronary atherosclerosis in young men,” Circulation, vol. 105, no. 23, pp. 2712–2718, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. J. A. E. Manson, G. A. Colditz, M. J. Stampfer et al., “A prospective study of obesity and risk of coronary heart disease in women,” New England Journal of Medicine, vol. 322, no. 13, pp. 882–889, 1990. View at Publisher · View at Google Scholar · View at Scopus
  14. P. W. F. Wilson, R. B. D'Agostino, L. Sullivan, H. Parise, and W. B. Kannel, “Overweight and obesity as determinants of cardiovascular risk: the Framingham experience,” Archives of Internal Medicine, vol. 162, no. 16, pp. 1867–1872, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Din-Dzietham, Y. Liu, M. V. Bielo, and F. Shamsa, “High blood pressure trends in children and adolescents in national surveys, 1963 to 2002,” Circulation, vol. 116, no. 13, pp. 1488–1496, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. M. C. Madala, B. A. Franklin, A. Y. Chen et al., “Obesity and age of first non-ST-segment elevation myocardial infarction,” Journal of the American College of Cardiology, vol. 52, no. 12, pp. 979–985, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. S. R. Das, K. P. Alexander, A. Y. Chen et al., “Impact of body weight and extreme obesity on the presentation, treatment, and in-hospital outcomes of 50,149 patients with ST-segment elevation myocardial infarction results from the NCDR (National Cardiovascular Data Registry),” Journal of the American College of Cardiology, vol. 58, no. 25, pp. 2642–2650, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Jamil, M. Jamil, H. Alkhazraji et al., “Risk factor assessment of young patients with acute myocardial infarction,” American Journal of Cardiovascular Disease, vol. 3, no. 3, pp. 170–174, 2013. View at Google Scholar
  19. C. J. Lavie, R. V. Milani, and H. O. Ventura, “Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss,” Journal of the American College of Cardiology, vol. 53, no. 21, pp. 1925–1932, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Mozaffarian, E. J. Benjamin, A. S. Go et al., “Heart disease and stroke statistics--2015 update: a report from the American Heart Association,” Circulation, vol. 131, no. 4, pp. e29–322, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Kenchaiah, J. C. Evans, D. Levy et al., “Obesity and the risk of heart failure,” New England Journal of Medicine, vol. 347, no. 5, pp. 305–313, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. M. A. Alpert, B. E. Terry, M. Mulekar et al., “Cardiac morphology and left ventricular function in normotensive morbidly obese patients with and without congestive heart failure, and effect of weight loss,” The American Journal of Cardiology, vol. 80, no. 6, pp. 736–740, 1997. View at Publisher · View at Google Scholar · View at Scopus
  23. M. A. Alpert, J. Omran, and B. P. Bostick, “Effects of obesity on cardiovascular hemodynamics, cardiac morphology, and ventricular function,” Current Obesity Reports, vol. 5, no. 4, pp. 424–434, 2016. View at Publisher · View at Google Scholar · View at Scopus
  24. R. E. Schmieder and F. H. Messerli, “Does obesity influence early target organ damage in hypertensive patients?” Circulation, vol. 87, no. 5, pp. 1482–1488, 1993. View at Publisher · View at Google Scholar · View at Scopus
  25. I. A. Ebong, D. C. Goff Jr., C. J. Rodriguez, H. Chen, and A. G. Bertoni, “Mechanisms of heart failure in obesity,” Obesity Research & Clinical Practice, vol. 8, no. 6, pp. e540–e548, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Rabbia, B. Silke, A. Conterno et al., “Assessment of cardiac autonomic modulation during adolescent obesity,” Obesity Research, vol. 11, no. 4, pp. 541–548, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Ahmed, M. R. Blackman, M. White, and S. D. Anker, “Emphasis on abdominal obesity as a modifier of eplerenone effect in heart failure: hypothesis-generating signals from EMPHASIS-HF,” European Journal of Heart Failure, vol. 19, no. 9, pp. 1198–1200, 2017. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Olivier, B. Pitt, N. Girerd et al., “Effect of eplerenone in patients with heart failure and reduced ejection fraction: potential effect modification by abdominal obesity. Insight from the EMPHASIS-HF trial,” European Journal of Heart Failure, vol. 19, no. 9, pp. 1186–1197, 2017. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Russo, F. Sera, Z. Jin et al., “Abdominal adiposity, general obesity, and subclinical systolic dysfunction in the elderly: a population-based cohort study,” European Journal of Heart Failure, vol. 18, no. 5, pp. 537–544, 2016. View at Publisher · View at Google Scholar · View at Scopus
  30. G. de Simone, V. Palmieri, J. N. Bella et al., “Association of left ventricular hypertrophy with metabolic risk factors: the HyperGEN study,” Journal of Hypertension, vol. 20, no. 2, pp. 323–331, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. B. Levine, J. Kalman, L. Mayer, H. M. Fillit, and M. Packer, “Elevated circulating levels of tumor necrosis factor in severe chronic heart failure,” The New England Journal of Medicine, vol. 323, no. 4, pp. 236–241, 1990. View at Publisher · View at Google Scholar · View at Scopus
  32. G. Torre-Amione, S. Kapadia, C. Benedict, H. Oral, J. B. Young, and D. L. Mann, “Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the studies of left ventricular dysfunction (SOLVD),” Journal of the American College of Cardiology, vol. 27, no. 5, pp. 1201–1206, 1996. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Tsutamoto, T. Hisanaga, A. Wada et al., “Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure,” Journal of the American College of Cardiology, vol. 31, no. 2, pp. 391–398, 1998. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Cavalera, J. H. Wang, and N. G. Frangogiannis, “Obesity, metabolic dysfunction, and cardiac fibrosis: pathophysiological pathways, molecular mechanisms, and therapeutic opportunities,” Translational Research, vol. 164, no. 4, pp. 323–335, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Karmazyn, D. M. Purdham, V. Rajapurohitam, and A. Zeidan, “Signalling mechanisms underlying the metabolic and other effects of adipokines on the heart,” Cardiovascular Research, vol. 79, no. 2, pp. 279–286, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. K. Schram and G. Sweeney, “Implications of myocardial matrix remodeling by adipokines in obesity-related heart failure,” Trends in Cardiovascular Medicine, vol. 18, no. 6, pp. 199–205, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. C. C. T. Smith and D. M. Yellon, “Adipocytokines, cardiovascular pathophysiology and myocardial protection,” Pharmacology & Therapeutics, vol. 129, no. 2, pp. 206–219, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. C. Lipina and H. S. Hundal, “Lipid modulation of skeletal muscle mass and function,” Journal of Cachexia, Sarcopenia and Muscle, vol. 8, no. 2, pp. 190–201, 2017. View at Publisher · View at Google Scholar · View at Scopus
  39. T. B. Horwich and G. C. Fonarow, “Glucose, obesity, metabolic syndrome, and diabetes relevance to incidence of heart failure,” Journal of the American College of Cardiology, vol. 55, no. 4, pp. 283–293, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. D. Cozzolino, A. Grandone, A. Cittadini et al., “Subclinical myocardial dysfunction and cardiac autonomic dysregulation are closely associated in obese children and adolescents: the potential role of insulin resistance,” PLoS One, vol. 10, no. 4, article e0123916, 2015. View at Publisher · View at Google Scholar · View at Scopus
  41. P. Poirier, T. D. Giles, G. A. Bray et al., “Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 5, pp. 968–976, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. B. A. Schoonderwoerd, M. D. Smit, L. Pen, and I. C. Van Gelder, “New risk factors for atrial fibrillation: causes of ‘not-so-lone atrial fibrillation’,” Europace, vol. 10, no. 6, pp. 668–673, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. O. Asghar, U. Alam, S. A. Hayat, R. Aghamohammadzadeh, A. M. Heagerty, and R. A. Malik, “Obesity, diabetes and atrial fibrillation; epidemiology, mechanisms and interventions,” Current Cardiology Reviews, vol. 8, no. 4, pp. 253–264, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. H. B. Hubert, M. Feinleib, P. M. McNamara, and W. P. Castelli, “Obesity as an independent risk factor for cardiovascular-disease: a 26-year follow-up of participants in the Framingham Heart Study,” Circulation, vol. 67, no. 5, pp. 968–977, 1983. View at Publisher · View at Google Scholar · View at Scopus
  45. T. J. Wang, H. Parise, D. Levy et al., “Obesity and the risk of new-onset atrial fibrillation,” JAMA, vol. 292, no. 20, pp. 2471–2477, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. Authors/Task Force Members, A. J. Camm, G. Y. H. Lip et al., “2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation: developed with the special contribution of the European Heart Rhythm Association,” Ep Europace, vol. 14, no. 10, pp. 1385–1413, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. U. B. Tedrow, D. Conen, P. M. Ridker et al., “The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation: the WHS (women’s health study),” Journal of the American College of Cardiology, vol. 55, no. 21, pp. 2319–2327, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. A. S. Gami, D. O. Hodge, R. M. Herges et al., “Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation,” Journal of the American College of Cardiology, vol. 49, no. 5, pp. 565–571, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. G. Di Salvo, G. Pacileo, E. M. Del Giudice et al., “Atrial myocardial deformation properties in obese nonhypertensive children,” Journal of the American Society of Echocardiography, vol. 21, no. 2, pp. 151–156, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. S. Zlochiver, V. Munoz, K. L. Vikstrom, S. M. Taffet, O. Berenfeld, and J. Jalife, “Electrotonic myofibroblast-to-myocyte coupling increases propensity to reentrant arrhythmias in two-dimensional cardiac monolayers,” Biophysical Journal, vol. 95, no. 9, pp. 4469–4480, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. B. Maesen, S. Zeemering, C. Afonso et al., “Rearrangement of atrial bundle architecture and consequent changes in anisotropy of conduction constitute the 3-dimensional substrate for atrial fibrillation,” Circulation: Arrhythmia and Electrophysiology, vol. 6, no. 5, pp. 967–975, 2013. View at Publisher · View at Google Scholar · View at Scopus
  52. J. Eckstein, S. Zeemering, D. Linz et al., “Transmural conduction is the predominant mechanism of breakthrough during atrial fibrillation: evidence from simultaneous endo-epicardial high-density activation mapping,” Circulation: Arrhythmia and Electrophysiology, vol. 6, no. 2, pp. 334–341, 2013. View at Publisher · View at Google Scholar · View at Scopus
  53. M. Pasarica, O. R. Sereda, L. M. Redman et al., “Reduced adipose tissue oxygenation in human obesity: evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic response,” Diabetes, vol. 58, no. 3, pp. 718–725, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. T. M. Munger, Y. X. Dong, M. Masaki et al., “Electrophysiological and hemodynamic characteristics associated with obesity in patients with atrial fibrillation,” Journal of the American College of Cardiology, vol. 60, no. 9, pp. 851–860, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. J. W. Magnani, F. L. Lopez, E. Z. Soliman, R. F. Maclehose, R. S. Crow, and A. Alonso, “P wave indices, obesity, and the metabolic syndrome: the atherosclerosis risk in communities study,” Obesity, vol. 20, no. 3, pp. 666–672, 2012. View at Publisher · View at Google Scholar · View at Scopus
  56. H. S. Abed, C. S. Samuel, D. H. Lau et al., “Obesity results in progressive atrial structural and electrical remodeling: implications for atrial fibrillation,” Heart Rhythm, vol. 10, no. 1, pp. 90–100, 2013. View at Publisher · View at Google Scholar · View at Scopus
  57. S. H. Lee, Y. C. Chen, Y. J. Chen et al., “Tumor necrosis factor-α alters calcium handling and increases arrhythmogenesis of pulmonary vein cardiomyocytes,” Life Sciences, vol. 80, no. 19, pp. 1806–1815, 2007. View at Publisher · View at Google Scholar · View at Scopus
  58. V. Mohamed-Ali, S. Goodrick, K. Bulmer, J. M. P. Holly, J. S. Yudkin, and S. W. Coppack, “Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo,” American Journal of Physiology-Endocrinology and Metabolism, vol. 277, no. 6, pp. E971–E975, 1999. View at Publisher · View at Google Scholar
  59. N. Venteclef, V. Guglielmi, E. Balse et al., “Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipo-fibrokines,” European Heart Journal, vol. 36, no. 13, pp. 795–805, 2015. View at Publisher · View at Google Scholar · View at Scopus
  60. E. M. Jeong, M. Liu, M. Sturdy et al., “Metabolic stress, reactive oxygen species, and arrhythmia,” Journal of Molecular and Cellular Cardiology, vol. 52, no. 2, pp. 454–463, 2012. View at Publisher · View at Google Scholar · View at Scopus
  61. A. Rossi, M. Enriquez-Sarano, J. C. Burnett Jr., A. Lerman, M. D. Abel, and J. B. Seward, “Natriuretic peptide levels in atrial fibrillation: a prospective hormonal and Doppler-echocardiographic study,” Journal of the American College of Cardiology, vol. 35, no. 5, pp. 1256–1262, 2000. View at Publisher · View at Google Scholar · View at Scopus
  62. G. Novo, D. Guttilla, G. Fazio, D. Cooper, and S. Novo, “The role of the renin-angiotensin system in atrial fibrillation and the therapeutic effects of ACE-Is and ARBS,” British Journal of Clinical Pharmacology, vol. 66, no. 3, pp. 345–351, 2008. View at Publisher · View at Google Scholar · View at Scopus
  63. K. Karason, H. Molgaard, J. Wikstrand, and L. Sjostrom, “Heart rate variability in obesity and the effect of weight loss,” The American Journal of Cardiology, vol. 83, no. 8, pp. 1242–1247, 1999. View at Publisher · View at Google Scholar · View at Scopus
  64. X. Jouven, M. Desnos, C. Guerot, and P. Ducimetiere, “Predicting sudden death in the population: the Paris Prospective Study I,” Circulation, vol. 99, no. 15, pp. 1978–1983, 1999. View at Publisher · View at Google Scholar · View at Scopus
  65. E. D. Abel, S. E. Litwin, and G. Sweeney, “Cardiac remodeling in obesity,” Physiological Reviews, vol. 88, no. 2, pp. 389–419, 2008. View at Publisher · View at Google Scholar · View at Scopus
  66. A. P. Lalani, B. Kanna, J. John, K. J. Ferrick, M. S. Huber, and L. E. Shapiro, “Abnormal signal-averaged electrocardiogram (SAECG) in obesity,” Obesity Research, vol. 8, no. 1, pp. 20–28, 2000. View at Publisher · View at Google Scholar · View at Scopus
  67. H. Huang, V. Amin, M. Gurin et al., “Diet-induced obesity causes long QT and reduces transcription of voltage-gated potassium channels,” Journal of Molecular and Cellular Cardiology, vol. 59, pp. 151–158, 2013. View at Publisher · View at Google Scholar · View at Scopus
  68. B. H. McCully, W. Hasan, C. T. Streiff et al., “Sympathetic cardiac hyperinnervation and atrial autonomic imbalance in diet-induced obesity promote cardiac arrhythmias,” American Journal of Physiology-Heart and Circulatory Physiology, vol. 305, no. 10, pp. H1530–H1537, 2013. View at Publisher · View at Google Scholar · View at Scopus
  69. K. Kalantar-Zadeh, G. Block, T. Horwich, and G. C. Fonarow, “Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure,” Journal of the American College of Cardiology, vol. 43, no. 8, pp. 1439–1444, 2004. View at Publisher · View at Google Scholar · View at Scopus
  70. A. Oreopoulos, R. Padwal, K. Kalantar-Zadeh, G. C. Fonarow, C. M. Norris, and F. A. McAlister, “Body mass index and mortality in heart failure: a meta-analysis,” American Heart Journal, vol. 156, no. 1, pp. 13–22, 2008. View at Publisher · View at Google Scholar · View at Scopus
  71. A. Romero-Corral, V. M. Montori, V. K. Somers et al., “Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies,” The Lancet, vol. 368, no. 9536, pp. 666–678, 2006. View at Publisher · View at Google Scholar · View at Scopus
  72. R. H. Mehta, R. M. Califf, J. Garg et al., “The impact of anthropomorphic indices on clinical outcomes in patients with acute ST-elevation myocardial infarction,” European Heart Journal, vol. 28, no. 4, pp. 415–424, 2007. View at Publisher · View at Google Scholar · View at Scopus
  73. A. O. Badheka, A. Rathod, M. A. Kizilbash et al., “Influence of obesity on outcomes in atrial fibrillation: yet another obesity paradox,” The American Journal of Medicine, vol. 123, no. 7, pp. 646–651, 2010. View at Publisher · View at Google Scholar · View at Scopus
  74. J. Wang, Y. M. Yang, J. Zhu, H. Zhang, and X. H. Shao, “Obesity paradox in patients with atrial fibrillation and heart failure,” International Journal of Cardiology, vol. 176, no. 3, pp. 1356–1358, 2014. View at Publisher · View at Google Scholar · View at Scopus
  75. A. Sharma, C. J. Lavie, J. S. Borer et al., “Meta-analysis of the relation of body mass index to all-cause and cardiovascular mortality and hospitalization in patients with chronic heart failure,” The American Journal of Cardiology, vol. 115, no. 10, pp. 1428–1434, 2015. View at Publisher · View at Google Scholar · View at Scopus
  76. B. Zafrir, N. Salman, M. G. Crespo-Leiro et al., “Body surface area as a prognostic marker in chronic heart failure patients: results from the Heart Failure Registry of the Heart Failure Association of the European Society of Cardiology,” European Journal of Heart Failure, vol. 18, no. 7, pp. 859–868, 2016. View at Publisher · View at Google Scholar · View at Scopus
  77. S. G. Ellis, J. Elliott, M. Horrigan, R. E. Raymond, and G. Howell, “Low-normal or excessive body mass index: newly identified and powerful risk factors for death and other complications with percutaneous coronary intervention,” The American Journal of Cardiology, vol. 78, no. 6, pp. 642–646, 1996. View at Publisher · View at Google Scholar · View at Scopus
  78. H. S. Gurm, P. L. Whitlow, K. E. Kip, and BARI Investigators, “The impact of body mass index on short- and long-term outcomes inpatients undergoing coronary revascularization: insights from the bypass angioplasty revascularization investigation (BARI),” Journal of the American College of Cardiology, vol. 39, no. 5, pp. 834–840, 2002. View at Publisher · View at Google Scholar · View at Scopus
  79. C. E. Hastie, S. Padmanabhan, R. Slack et al., “Obesity paradox in a cohort of 4880 consecutive patients undergoing percutaneous coronary intervention,” European Heart Journal, vol. 31, no. 2, pp. 222–226, 2010. View at Publisher · View at Google Scholar · View at Scopus
  80. A. Oreopoulos, F. A. McAlister, K. Kalantar-Zadeh et al., “The relationship between body mass index, treatment, and mortality in patients with established coronary artery disease: a report from APPROACH,” European Heart Journal, vol. 30, no. 21, pp. 2584–2592, 2009. View at Publisher · View at Google Scholar · View at Scopus
  81. E. Nikolsky, E. Kosinski, G. J. Mishkel et al., “Impact of obesity on revascularization and restenosis rates after bare-metal and drug-eluting stent implantation (from the TAXUS-IV trial),” The American Journal of Cardiology, vol. 95, no. 6, pp. 709–715, 2005. View at Publisher · View at Google Scholar · View at Scopus
  82. I. Akin, R. Tölg, M. Hochadel et al., “No evidence of “obesity paradox” after treatment with drug-eluting stents in a routine clinical practice: results from the prospective multicenter German DES.DE (German Drug-Eluting Stent) Registry,” JACC: Cardiovascular Interventions, vol. 5, no. 2, pp. 162–169, 2012. View at Publisher · View at Google Scholar · View at Scopus
  83. L. Gruberg, N. J. Weissman, R. Waksman et al., “The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox?” Journal of the American College of Cardiology, vol. 39, no. 4, pp. 578–584, 2002. View at Publisher · View at Google Scholar · View at Scopus
  84. D. R. Holmes Jr, H. D. White, K. S. Pieper, S. G. Ellis, R. M. Califf, and E. J. Topol, “Effect of age on outcome with primary angioplasty versus thrombolysis,” Journal of the American College of Cardiology, vol. 33, no. 2, pp. 412–419, 1999. View at Publisher · View at Google Scholar · View at Scopus
  85. E. E. Calle, M. J. Thun, J. M. Petrelli, C. Rodriguez, and C. W. Heath Jr, “Body-mass index and mortality in a prospective cohort of U.S. adults,” New England Journal of Medicine, vol. 341, no. 15, pp. 1097–1105, 1999. View at Publisher · View at Google Scholar · View at Scopus
  86. C. J. Lavie and H. O. Ventura, “Weighing in on obesity and the obesity paradox in heart failure,” Journal of Cardiac Failure, vol. 17, no. 5, pp. 381–383, 2011. View at Publisher · View at Google Scholar · View at Scopus
  87. C. Kistorp, J. Faber, S. Galatius et al., “Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure,” Circulation, vol. 112, no. 12, pp. 1756–1762, 2005. View at Publisher · View at Google Scholar · View at Scopus
  88. G. O'Donovan, A. Owen, E. M. Kearney et al., “Cardiovascular disease risk factors in habitual exercisers, lean sedentary men and abdominally obese sedentary men,” International Journal of Obesity, vol. 29, no. 9, pp. 1063–1069, 2005. View at Publisher · View at Google Scholar · View at Scopus
  89. C. Goossens, M. B. Marques, S. Derde et al., “Premorbid obesity, but not nutrition, prevents critical illness-induced muscle wasting and weakness,” Journal of Cachexia, Sarcopenia and Muscle, vol. 8, no. 1, pp. 89–101, 2017. View at Publisher · View at Google Scholar · View at Scopus
  90. M. De Rosa, J. Gambardella, J. Shu, and G. Santulli, “Dietary fat is a key determinant in balancing mitochondrial dynamics in heart failure: a novel mechanism underlying the obesity paradox,” Cardiovascular Research, vol. 114, no. 7, pp. 925–927, 2018. View at Publisher · View at Google Scholar · View at Scopus
  91. J. Gambardella, B. Trimarco, G. Iaccarino, and G. Santulli, “New insights in cardiac calcium handling and excitation-contraction coupling,” Advances in Experimental Medicine and Biology, vol. 1067, pp. 373–385, 2018. View at Publisher · View at Google Scholar · View at Scopus
  92. Y. Guo, Z. Wang, X. Qin et al., “Enhancing fatty acid utilization ameliorates mitochondrial fragmentation and cardiac dysfunction via rebalancing optic atrophy 1 processing in the failing heart,” Cardiovascular Research, vol. 114, no. 7, pp. 979–991, 2018. View at Publisher · View at Google Scholar · View at Scopus
  93. H. Schunkert, L. Harrell, and I. F. Palacios, “Implications of small reference vessel diameter in patients undergoing percutaneous coronary revascularization,” Journal of the American College of Cardiology, vol. 34, no. 1, pp. 40–48, 1999. View at Publisher · View at Google Scholar · View at Scopus
  94. D. P. Foley, R. Melkert, and P. W. Serruys, “Influence of coronary vessel size on renarrowing process and late angiographic outcome after successful balloon angioplasty,” Circulation, vol. 90, no. 3, pp. 1239–1251, 1994. View at Publisher · View at Google Scholar · View at Scopus
  95. B. D. Powell, R. J. Lennon, A. Lerman et al., “Association of body mass index with outcome after percutaneous coronary intervention,” The American Journal of Cardiology, vol. 91, no. 4, pp. 472–476, 2003. View at Publisher · View at Google Scholar · View at Scopus
  96. P. Chase, R. Arena, J. Myers et al., “Relation of the prognostic value of ventilatory efficiency to body mass index in patients with heart failure,” The American Journal of Cardiology, vol. 101, no. 3, pp. 348–352, 2008. View at Publisher · View at Google Scholar · View at Scopus
  97. E. G. Artero, D. C. Lee, C. J. Lavie et al., “Effects of muscular strength on cardiovascular risk factors and prognosis,” Journal of Cardiopulmonary Rehabilitation and Prevention, vol. 32, no. 6, pp. 351–358, 2012. View at Publisher · View at Google Scholar · View at Scopus
  98. A. L. Clark, “Tipping the scales toward fitness as a key modifier of the obesity paradox in heart failure,” European Journal of Heart Failure, vol. 18, no. 5, pp. 554-555, 2016. View at Publisher · View at Google Scholar · View at Scopus
  99. M. F. Piepoli, U. Corrà, F. Veglia et al., “Exercise tolerance can explain the obesity paradox in patients with systolic heart failure: data from the MECKI Score Research Group,” European Journal of Heart Failure, vol. 18, no. 5, pp. 545–553, 2016. View at Publisher · View at Google Scholar · View at Scopus
  100. E. Zamora, J. Lupón, C. Enjuanes et al., “No benefit from the obesity paradox for diabetic patients with heart failure,” European Journal of Heart Failure, vol. 18, no. 7, pp. 851–858, 2016. View at Publisher · View at Google Scholar · View at Scopus
  101. M. F. Piepoli, “Obesity in heart failure: is it time to rethink the paradox?” European Journal of Heart Failure, vol. 19, no. 12, p. 1736, 2017. View at Publisher · View at Google Scholar · View at Scopus
  102. C. Cuspidi, M. Rescaldani, C. Sala, and G. Grassi, “Left-ventricular hypertrophy and obesity: a systematic review and meta-analysis of echocardiographic studies,” Journal of Hypertension, vol. 32, no. 1, pp. 16–25, 2014. View at Publisher · View at Google Scholar · View at Scopus
  103. I. E. G. M. Rocha, E. G. Victor, M. C. Braga, O. B. e. Silva, and M. d. M. C. Becker, “Echocardiography evaluation for asymptomatic patients with severe obesity,” Arquivos Brasileiros de Cardiologia, vol. 88, no. 1, pp. 52–58, 2007. View at Publisher · View at Google Scholar · View at Scopus
  104. S. F. Nagueh, C. P. Appleton, T. C. Gillebert et al., “Recommendations for the evaluation of left ventricular diastolic function by echocardiography,” Journal of the American Society of Echocardiography, vol. 22, no. 2, pp. 107–133, 2009. View at Publisher · View at Google Scholar · View at Scopus
  105. V. Di Bello, I. Fabiani, L. Conte et al., “New echocardiographic techniques in the evaluation of left ventricular function in obesity,” Obesity (Silver Spring), vol. 21, no. 5, pp. 881–892, 2013. View at Publisher · View at Google Scholar · View at Scopus
  106. M. Murat Tumuklu, I. Etikan, B. Kisacik, and M. Kayikcioglu, “Effect of obesity on left ventricular structure and myocardial systolic function: assessment by tissue Doppler imaging and strain/strain rate imaging,” Echocardiography, vol. 24, no. 8, pp. 802–809, 2007. View at Publisher · View at Google Scholar · View at Scopus
  107. M. R. Holland, K. D. Wallace, and J. G. Miller, “Potential relationships among myocardial stiffness, the measured level of myocardial backscatter (“image brightness”), and the magnitude of the systematic variation of backscatter (cyclic variation) over the heart cycle,” Journal of the American Society of Echocardiography, vol. 17, no. 11, pp. 1131–1137, 2004. View at Publisher · View at Google Scholar · View at Scopus
  108. S. A. Wickline, L. J. Thomas 3rd, J. G. Miller, B. E. Sobel, and J. E. Perez, “A relationship between ultrasonic integrated backscatter and myocardial contractile function,” Journal of Clinical Investigation, vol. 76, no. 6, pp. 2151–2160, 1985. View at Publisher · View at Google Scholar · View at Scopus
  109. T. Edvardsen, B. L. Gerber, J́̂. Garot, D. A. Bluemke, J̃. A. C. Lima, and O. A. Smiseth, “Quantitative assessment of intrinsic regional myocardial deformation by Doppler strain rate echocardiography in humans: validation against three-dimensional tagged magnetic resonance imaging,” Circulation, vol. 106, no. 1, pp. 50–56, 2002. View at Publisher · View at Google Scholar · View at Scopus
  110. R. M. Lang, L. P. Badano, W. Tsang et al., “EAE/ASE recommendations for image acquisition and display using three-dimensional echocardiography,” Journal of the American Society of Echocardiography, vol. 25, no. 1, pp. 3–46, 2012. View at Publisher · View at Google Scholar · View at Scopus
  111. A. el-Gamal, D. Gallagher, A. Nawras et al., “Effects of obesity on QT, RR, and QTc intervals,” The American Journal of Cardiology, vol. 75, no. 14, pp. 956–959, 1995. View at Publisher · View at Google Scholar · View at Scopus
  112. M. E. Mshui, T. Saikawa, K. Ito, M. Hara, and T. Sakata, “QT interval and QT dispersion before and after diet therapy in patients with simple obesity,” Proceedings of the Society for Experimental Biology and Medicine, vol. 220, no. 3, pp. 133–138, 1999. View at Publisher · View at Google Scholar
  113. A. Lubinski, Z. Kornacewicz-Jach, A. M. Wnuk-Wojnar et al., “The terminal portion of the T wave: a new electrocardiographic marker of risk of ventricular arrhythmias,” Pacing and Clinical Electrophysiology, vol. 23, no. 11P2, pp. 1957–1959, 2000. View at Publisher · View at Google Scholar · View at Scopus
  114. M. Shimizu, H. Ino, K. Okeie et al., “T-peak to T-end interval may be a better predictor of high-risk patients with hypertrophic cardiomyopathy associated with a cardiac troponin I mutation than QT dispersion,” Clinical Cardiology, vol. 25, no. 7, pp. 335–339, 2002. View at Publisher · View at Google Scholar · View at Scopus
  115. M. Yamaguchi, M. Shimizu, H. Ino et al., “T wave peak-to-end interval and QT dispersion in acquired long QT syndrome: a new index for arrhythmogenicity,” Clinical Science, vol. 105, no. 6, pp. 671–676, 2003. View at Publisher · View at Google Scholar · View at Scopus
  116. A. Braschi, M. G. Abrignani, V. C. Francavilla, and G. Francavilla, “Novel Electrocardiographic Parameters of Altered Repolarization in Uncomplicated Overweight and Obesity,” Obesity, vol. 19, no. 4, pp. 875–881, 2010. View at Publisher · View at Google Scholar · View at Scopus